Scientific program

Thursday, November 8, 2018

 15:00 – 16:00 Opening Session Hall A
Chairperson  Jean-Pierre Pelletier, Canada
15:00 – 15:30 General Welcome
Jean-Pierre Pelletier, Canada
Johanne Martel-Pelletier, Canada
Boulos Haraoui, Canada
15:30 – 16:00 Guest Lecture:
 16:00 – 16:10 Break
16:10 – 17:00 Asia Pacific League of Associations for Rheumatology (APLAR) Symposium:
Recent progress on genetic and cellular rheumatology in APLAR
Hall A
Speakers Huji Xu, China
Kazuhiko Yamamoto, Japan
 17:00 – 17:10 Break
 17:10 – 18:00 Industry Symposium
Supported by Mylan
Hall A
 18:00 Networking Reception

Friday, November 9, 2018

08:00 – 08:50 Session:
JAK inhibitors should be first line before biologic agents

Hall A
Chairperson  
08:00 Pros and cons of JAK inhibitors over biologic DMARDs
Mark C. Genovese, USA
08:20 How to start and how taper to JAK inhibitors
Tsutomo Takeuchi, Japan
08:40 Discussion
 08:50 – 09:00 Break
 09:00 – 09:50 Industry Symposium
Supported by Eli Lilly
Hall A
 09:50 – 10:00 Break
10:00 – 10:50 Session:
How to deal with vaccination of patients with inflammatory arthritis

Hall A
Chairperson  
10:00 Practical application of an immunization program in patients with inflammatory arthritis
Boulos Haraoui, Canada
10:20 Vaccination in patients with inflammatory arthritis – are they really safe?
Worawit Louthrenoo, Thailand
10:40 Discussion
 10:50 – 11:00 Break
11:00 – 11:50 Meet the Experts:
Inflammation in osteoarthritis as a therapeutic target

Hall A
Chairperson  
11:00 Inflammation in osteoarthritis. Local, systemic or both: Therapeutic implications
Johanne Martel-Pelletier, Canada
11:20 The role of matrix degradation product in the inflammation and pain in OA
Hyun Ah Kim, Korea
11:40 Discussion
 11:50 – 12:00 Break
 12:00 – 12:50 Industry Symposium
Supported by TRB
Hall A
 12:50 – 13:00 Break
13:00 – 13:50 Meet the Experts:
How to best manage osteoporosis in patients with arthritis

Hall A
Chairperson  
13:00 Treatment of glucocorticoid-induced osteoporosis
Graeme Jones, Australia
13:20 Risk factors for osteoporosis in patients with arthritis
Swan Sim Yeap, Malaysia
13:40 Discussion
 13:50 – 14:00 Break
14:00 – 14:50 Session:
Osteoarthritis, a disease of the bone/subchondral bone?
Implication for treatment

Hall A
Chairperson  
14:00 TBA
14:20 Bisphosphonates in OA: What is the evidence?
Rohini Handa, India
14:40 Discussion
 14:50 – 15:00 Break
15:00 – 15:50 Session:
Biosimilars: Are rheumatologists and patients ready for transitioning patients from an originator to a biosimilar?
Hall A
Chairperson  
15:00 European experience with switching from originator to biosimilar products in rheumatology
Tore Kvien, Norway
15:20 The impact of biosimilars in the treatment of rheumatoid arthritis: Similarities and differences of biosimilars compared to original biologics
Yeong-Wook Song, Korea
15:40 Discussion
 15:50 – 16:00 Break
 16:00 – 16:50 Industry Symposium
Supported by Celltrion
Hall A
 16:50 – 17:00 Break
 17:00 – 18:00 Guided Poster Tour
Supported by Samumed

Saturday, November 10, 2018

08:00 – 08:50 Session:
Management of challenging osteoarthritis cases in daily practice: Well-kept secrets
Hall A
Chairperson  
08:00 What to do when nothing really works ? A Canadian approach
Jean-Pierre Raynauld, Canada
08:20 Treatment of osteoarthritis: An Australian perspective
Graeme Jones, Australia
08:40 Discussion
 08:50 – 09:00 Break
09:00 – 09:50 Session:
When is biologic monotherapy the treatment of choice?
Hall A
Chairperson  
09:00 Biologic monotherapy is rarely the treatment of choice
Kevin Pile, Australia
09:20 The benefit and timing of biologic monotherapy
Tsutomu Takeuchi, Japan
09:40 Discussion
 09:50 – 10:00 Break
10:00 – 10:50 Session:
Novel therapeutic targets and cellular therapies for osteoarthritis
Hall A
Chairperson  
10:00 TBA
Mohit Kapoor, Canada
10:20 TBA
10:40 Discussion
 10:50 – 11:00 Break
11:00 – 11:50 Session:
Psoriatic arthritis: How to balance management of the skin and the joints
Hall A
Chairperson  
11:00 Diagnosis and management of psoriatic disease: A domain-based approach
Christopher T. Ritchlin, USA
11:20 Evolving therapies of psoriasis
Paulo Lorenzo, Philippines
11:40 Discussion
 11:50 – 12:00 Break
12:00 – 12:50 Industry Lunch Symposium
Hall A
 12:50 – 13:00 Break
 13:00 – 13:30 Poster Viewing
13:30 – 14:20 Meet the Experts:
Non-radiographic spondyloarthropathy: If you were paying for it, would you commence biologic therapy?
Hall A
Chairperson  
13:30 TBA
13:50 The purpose of treating non-radiographic spondyloarthropathy, structure preservation
or function restoration? Is it cost-effective when using biologic therapy?
Wen Chan Tsai, Taiwan
14:10 Discussion
 14:20 – 14:30 Break
14:30 – 15:20 Session:
Intraarticular therapy for arthritis: Interesting new findings for patients
Hall A
Chairperson  
14:30 Viscosupplementation: What have we learned from 25 years of experience?
Jean-Pierre Raynauld, Canada
14:50 Intraarticular corticosteroid and newbies
Ying Ying Katy Leung, Singapore
15:10 Discussion
 15:20 – 15:30 Break
15:30 – 16:20 Meet the Experts:
Lupus and pregnancy: Good news for the doctor and the mother
Hall A
Chairperson  
15:30 Treatment challenges in lupus pregnancy
Monika Østensen, Norway
15:50 Improving outcomes of lupus related recurrent abortion
Chak-Sing Lau, Hong Kong
16:10 Discussion
 16:20 – 16:30 Break
16:30 – 17:00 Oral Abstracts and Award Presentations
Hall A
Chairperson  
16:00 Presentation to Abstract Awardees
16:05 Best Abstract 1
16:15 Best Abstract 2
16:25 Questions